FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366156682> ?p ?o ?g. }

• W4366156682 endingPage "101487" @default.
• W4366156682 startingPage "101487" @default.
• W4366156682 abstract "Although there is increasing interest in conducting cancer clinical trials in older adults, the benefit of such trials is unclear. We aimed to quantify the real-world clinical and economic effects of two phase 3 trials (CALGB 9343 and PRIME II) which showed that post-lumpectomy radiation therapy (RT) improves loco-regional recurrence but makes no improvement in overall survival among older women with early-stage breast cancer (ESBC).We developed a health-transition model to quantify the incremental clinical and economic outcomes between scenarios with vs. without older adult-specific trial results from a societal perspective between 2004 and 2018. The transition probabilities in the model were mainly derived from the 10-year results of CALGB 9343. The total number of the affected patient population in the US and the change in the probability of omitting post-lumpectomy RT due to the CALGB 9343 and PRIME II results were derived from a retrospective analysis of the SEER registry data for patients with ESBC. Sensitivity analyses were conducted to calculate the 95% credible interval (CR) of the incremental clinical and economic outcomes between the two scenarios.Between 2004 and 2018, 32,936 (95% CR: 31,512, 34,357) fewer patients received post-lumpectomy RT among those aged 70 years or older diagnosed with ESBC in the US and there was a decrease cost of $419 M USD (95% CR: -$238 M, -$689 M) in scenarios with vs. without older adult-specific trial results. The difference in projected life years (1083 years, 95% CI: -2542, 7985) and QALYs (866 years, 95% CI: -2561, 7780) were not significant. At a willingness-to-pay threshold of $100 k/QALY, the probability of older adult-specific trial results generating a positive net monetary benefit was 98%.The CALGB 9343 and PRIME II trial results were associated with a substantial cost-saving in the US society. Our results suggest that older adult-specific clinical trials that demonstrate no survival benefit of an intervention in older adults could be correlated with a significant monetary benefit. Further case studies are needed for different types of older adult-specific trials to understand the value of older adult-specific trials comprehensively." @default.
• W4366156682 created "2023-04-19" @default.
• W4366156682 creator A5010153281 @default.
• W4366156682 creator A5032696513 @default.
• W4366156682 creator A5068073076 @default.
• W4366156682 creator A5085042140 @default.
• W4366156682 date "2023-05-01" @default.
• W4366156682 modified "2023-09-27" @default.
• W4366156682 title "Quantifying the value of older adult-specific clinical trials: Post-lumpectomy irradiation among older adults with early-stage breast cancer" @default.
• W4366156682 cites W1979871017 @default.
• W4366156682 cites W1982853521 @default.
• W4366156682 cites W1990637325 @default.
• W4366156682 cites W2022034315 @default.
• W4366156682 cites W2036396804 @default.
• W4366156682 cites W2044658894 @default.
• W4366156682 cites W2062170619 @default.
• W4366156682 cites W2067420088 @default.
• W4366156682 cites W2092530442 @default.
• W4366156682 cites W2096499183 @default.
• W4366156682 cites W2103608035 @default.
• W4366156682 cites W2104793011 @default.
• W4366156682 cites W2108318793 @default.
• W4366156682 cites W2113227626 @default.
• W4366156682 cites W2121095198 @default.
• W4366156682 cites W2122428334 @default.
• W4366156682 cites W2128585633 @default.
• W4366156682 cites W2137757474 @default.
• W4366156682 cites W2148505042 @default.
• W4366156682 cites W2149386818 @default.
• W4366156682 cites W2168124422 @default.
• W4366156682 cites W2168579528 @default.
• W4366156682 cites W2460621480 @default.
• W4366156682 cites W2487037907 @default.
• W4366156682 cites W2526851200 @default.
• W4366156682 cites W2604727356 @default.
• W4366156682 cites W2615117870 @default.
• W4366156682 cites W2789980412 @default.
• W4366156682 cites W2795581839 @default.
• W4366156682 cites W2890163109 @default.
• W4366156682 cites W2921099093 @default.
• W4366156682 cites W2978515564 @default.
• W4366156682 cites W3031623342 @default.
• W4366156682 cites W3084378266 @default.
• W4366156682 cites W3091199432 @default.
• W4366156682 cites W3093453856 @default.
• W4366156682 cites W3126194048 @default.
• W4366156682 cites W3127720839 @default.
• W4366156682 cites W3163245245 @default.
• W4366156682 cites W3207452053 @default.
• W4366156682 cites W3211678510 @default.
• W4366156682 doi "https://doi.org/10.1016/j.jgo.2023.101487" @default.
• W4366156682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37075565" @default.
• W4366156682 hasPublicationYear "2023" @default.
• W4366156682 type Work @default.
• W4366156682 citedByCount "0" @default.
• W4366156682 crossrefType "journal-article" @default.
• W4366156682 hasAuthorship W4366156682A5010153281 @default.
• W4366156682 hasAuthorship W4366156682A5032696513 @default.
• W4366156682 hasAuthorship W4366156682A5068073076 @default.
• W4366156682 hasAuthorship W4366156682A5085042140 @default.
• W4366156682 hasConcept C121608353 @default.
• W4366156682 hasConcept C126322002 @default.
• W4366156682 hasConcept C143998085 @default.
• W4366156682 hasConcept C146357865 @default.
• W4366156682 hasConcept C151730666 @default.
• W4366156682 hasConcept C2777757722 @default.
• W4366156682 hasConcept C2779572924 @default.
• W4366156682 hasConcept C2908647359 @default.
• W4366156682 hasConcept C509974204 @default.
• W4366156682 hasConcept C530470458 @default.
• W4366156682 hasConcept C535046627 @default.
• W4366156682 hasConcept C71924100 @default.
• W4366156682 hasConcept C86803240 @default.
• W4366156682 hasConcept C99454951 @default.
• W4366156682 hasConceptScore W4366156682C121608353 @default.
• W4366156682 hasConceptScore W4366156682C126322002 @default.
• W4366156682 hasConceptScore W4366156682C143998085 @default.
• W4366156682 hasConceptScore W4366156682C146357865 @default.
• W4366156682 hasConceptScore W4366156682C151730666 @default.
• W4366156682 hasConceptScore W4366156682C2777757722 @default.
• W4366156682 hasConceptScore W4366156682C2779572924 @default.
• W4366156682 hasConceptScore W4366156682C2908647359 @default.
• W4366156682 hasConceptScore W4366156682C509974204 @default.
• W4366156682 hasConceptScore W4366156682C530470458 @default.
• W4366156682 hasConceptScore W4366156682C535046627 @default.
• W4366156682 hasConceptScore W4366156682C71924100 @default.
• W4366156682 hasConceptScore W4366156682C86803240 @default.
• W4366156682 hasConceptScore W4366156682C99454951 @default.
• W4366156682 hasIssue "4" @default.
• W4366156682 hasLocation W43661566821 @default.
• W4366156682 hasLocation W43661566822 @default.
• W4366156682 hasOpenAccess W4366156682 @default.
• W4366156682 hasPrimaryLocation W43661566821 @default.
• W4366156682 hasRelatedWork W2035650590 @default.
• W4366156682 hasRelatedWork W2074391593 @default.
• W4366156682 hasRelatedWork W2099316122 @default.
• W4366156682 hasRelatedWork W2106765698 @default.
• W4366156682 hasRelatedWork W2171408781 @default.

• next